Novel Oronasal Drainage for Long COVID: Proposed Mechanisms-Case Report.
Lorenz, Claudia, Frankenberger, Roland · Viruses · 2025 · DOI
Quick Summary
Researchers tested a new treatment called oronasal drainage (OND) for Long COVID, which involves a gentle abrasive therapy targeting the drainage areas in the nose and mouth. In one patient case, this treatment appeared to reduce various Long COVID symptoms and improve blood circulation to the hands. While these results are promising, the study was very small and more research is needed to confirm whether this treatment actually works.
Why It Matters
This study offers a novel mechanistic framework for understanding potential dysfunction in oronasal drainage and lymphatic clearance in Long COVID, conditions that may parallel dysfunction in ME/CFS. Given the overlap between Long COVID and ME/CFS populations, exploring new physiological targets and treatment approaches could benefit both patient communities, even as rigorous validation remains essential.
Observed Findings
Patient reported reduction in various Long COVID symptoms following OND treatment
Enhanced hand blood circulation was documented in the treated patient
No serious adverse events were reported from the intervention
Symptom improvement occurred following the novel oronasal drainage procedure
Inferred Conclusions
OND may target a previously unrecognized physiological dysfunction in Long COVID through combined physiological, biochemical, and fluid mechanical mechanisms
Further validation through controlled clinical trials is necessary to determine if observed improvements represent genuine treatment efficacy
The proposed mechanism involving epipharyngeal and oronasal drainage warrants investigation in larger, more rigorous studies
Remaining Questions
Does OND produce clinically meaningful benefits in a larger, controlled patient population with Long COVID or ME/CFS?
What is the optimal technique, frequency, and duration of OND treatment, and how do these parameters affect outcomes?
What is the biological mechanism by which epipharyngeal abrasive therapy might reduce Long COVID symptoms, and is it related to lymphatic clearance or immune modulation?
What This Study Does Not Prove
This case report does not establish that OND is an effective treatment for Long COVID, as a single case cannot prove efficacy or determine causation. It does not rule out placebo effects or natural symptom resolution over time. The study provides no evidence that this approach would work for patients beyond this individual case or that improvement would be sustained long-term.
Tags
Symptom:Fatigue
Biomarker:Blood Biomarker
Phenotype:Infection-TriggeredLong COVID Overlap
Method Flag:PEM Not DefinedWeak Case DefinitionNo ControlsSmall SampleExploratory Only